Literature DB >> 33588071

XIAP, commonly targeted by tumor suppressive miR-3607-5p and miR-3607-3p, promotes proliferation and inhibits apoptosis in hepatocellular carcinoma.

Weiyang Lou1, Jing Chen2, Bisha Ding3, Weimin Fan4.   

Abstract

MicroRNAs (miRNAs) are frequently aberrantly expressed in hepatocellular carcinoma (HCC) and are involved in its development. However, their role and mechanism in HCC are still not fully elucidated. Differential expression analysis and survival analysis were performed to identify potential miRNAs in HCC and miR-3607 was identified as a candidate therapeutic target and prognostic biomarker. RT-qPCR confirmed the low expression of mature miR-3607-3p and miR-3607-5p in HCC. Functional experiments suggested that both miR-3607-3p and miR-3607-5p significantly inhibited HCC proliferation and induced apoptosis. Next, the detailed mechanism of miR-3607-3p and miR-3607-5p in HCC was explored by combination of bioinformatic analysis and experimental validation, and uncovered that XIAP, a common target gene of miR-3607-3p and miR-3607-5p, was involoved in their tumor suppressive effects. Finally, a XIAP-associated protein-protein interaction network, consisting of 10 positively correlated genes, was established. Collectively, we for the first time suggest that miR-3607-3p and miR-3607-5p inhibit HCC by acting one common target XIAP.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Apoptosis; Biomarker; Hepatocellular carcinoma; Proliferation; Therapeutic target; X-linked inhibitor of apoptosis (XIAP); miR-3607

Mesh:

Substances:

Year:  2021        PMID: 33588071     DOI: 10.1016/j.ygeno.2021.02.003

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  3 in total

1.  Cuproptosis-related gene SLC31A1 is a potential predictor for diagnosis, prognosis and therapeutic response of breast cancer.

Authors:  Xiao Li; Zhaosheng Ma; Linhang Mei
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

2.  Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical Validation.

Authors:  Areeg M Dabbish; Hana M Abdelzaher; Moustafa Abohawya; Samir Shamma; Yosra H Mahmoud; Amr Maged; Mohamed Manaa; Mohamed Hassany; Firas Kobeissy; Omid Bazgir; Hassan El-Fawal; Hassan M E Azzazy; Anwar Abdelnaser
Journal:  Cancers (Basel)       Date:  2022-06-21       Impact factor: 6.575

3.  Identification of multi-omics biomarkers and construction of the novel prognostic model for hepatocellular carcinoma.

Authors:  Xiao Liu; Chiying Xiao; Kunyan Yue; Min Chen; Hang Zhou; Xiaokai Yan
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.